Shire plc (LSE: SHP, NASDAQ: SHPG), the global specialty biopharmaceutical company was notified today that, on August 6, 2012, Kevin Rakin sold 10,000 American Depository Shares (“ADSs”) at a price of $91.4776 per ADS. One ADS is equal to three Shire plc ordinary shares.
This notification relates to disclosures made in accordance with 3.1.4(R)(1)(a) of the Disclosure and Transparency Rules.
Deputy Company Secretary
For further information please contact:
|Eric Rojasemail@example.com||+1 781 482 0999|
|Sarah Elton-Farrfirstname.lastname@example.org||+44 1256 894157|
Notes to editors
Shire enables people with life-altering conditions to lead better lives.
Through our deep understanding of patients’ needs, we develop and provide healthcare in the areas of:
as well as other symptomatic conditions treated by specialist physicians.
We aspire to imagine and lead the future of healthcare, creating value for patients, physicians, policymakers, payors and our shareholders.